These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34053902)

  • 1. Severe asthma in the era of COVID-19: A narrative review.
    Gaspar-Marques J; van Zeller M; Carreiro-Martins P; Chaves Loureiro C
    Pulmonology; 2022; 28(1):34-43. PubMed ID: 34053902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological therapies, asthma and coronavirus disease 2019.
    Ribeiro A; Aguiar R; Morais-Almeida M
    Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):597-601. PubMed ID: 34545041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma-associated risk for COVID-19 development.
    Skevaki C; Karsonova A; Karaulov A; Xie M; Renz H
    J Allergy Clin Immunol; 2020 Dec; 146(6):1295-1301. PubMed ID: 33002516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019.
    Timberlake DT; Strothman K; Grayson MH
    Curr Opin Allergy Clin Immunol; 2021 Apr; 21(2):182-187. PubMed ID: 33399389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics.
    Papaioannou AI; Fouka E; Tzanakis N; Antoniou K; Samitas K; Zervas E; Kostikas K; Bartziokas K; Porpodis K; Papakosta D; Tzouvelekis A; Gerogianni I; Kotsiou O; Makris M; Rovina N; Vlachou G; Markatos M; Vittorakis S; Katsoulis K; Papanikolaou I; Afthinos A; Katsaounou P; Steiropoulos P; Latsios D; Dimakou K; Koukidou S; Hillas G; Tryfon S; Kallieri M; Georgopoulou A; Avarlis P; Bakakos P; Markopoulou K; Gaki E; Paspala A; Kyriakaki Z; Gourgoulianis KI; Papiris S; Loukides S
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2588-2595. PubMed ID: 35752436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent insights into the impacts of COVID-19 on pediatric asthma.
    da Silva Alves C; Baptista Pestana R; Morais-Almeida M
    Expert Rev Clin Immunol; 2024 Nov; 20(11):1347-1366. PubMed ID: 39136081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 in Children with Asthma.
    Chatziparasidis G; Kantar A
    Lung; 2021 Feb; 199(1):7-12. PubMed ID: 33496842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of biologics in severe asthmatic patients with SARS-CoV-2 infection: A prospective study.
    Manti S; Giallongo A; Pecora G; Parisi GF; Papale M; Mulè E; Aloisio D; Rotolo N; Leonardi S
    Pediatr Pulmonol; 2023 Apr; 58(4):1085-1091. PubMed ID: 36593591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.
    Adir Y; Humbert M; Saliba W
    J Allergy Clin Immunol; 2021 Aug; 148(2):361-367.e13. PubMed ID: 34144110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma in the era of SARS CoV-2 virus.
    Bakakos A; Krompa A
    J Asthma; 2022 Aug; 59(8):1501-1508. PubMed ID: 34112029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viruses and asthma: the role of common respiratory viruses in asthma and its potential meaning for SARS-CoV-2.
    Novak N; Cabanillas B
    Immunology; 2020 Oct; 161(2):83-93. PubMed ID: 32687609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe asthma and COVID-19: lessons from the first wave.
    Patrucco F; Benfante A; Villa E; Principe S; Scichilone N; Solidoro P
    J Asthma; 2022 Feb; 59(2):239-242. PubMed ID: 33297799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in clinical outcomes: What we have learned during the COVID-19 pandemic.
    Al-Musa A; LaBere B; Habiballah S; Nguyen AA; Chou J
    J Allergy Clin Immunol; 2022 Feb; 149(2):569-578. PubMed ID: 34958811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
    Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
    Front Immunol; 2021; 12():589095. PubMed ID: 33995341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral infections causing asthma exacerbations in the age of biologics and the COVID-19 pandemic.
    Lamothe PA; Capric V; Lee FE
    Curr Opin Pulm Med; 2024 May; 30(3):287-293. PubMed ID: 38411178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidance for Administering Biologics for Severe Asthma and Allergic Conditions.
    Dorscheid DR; Lee JK; Ramesh W; Greenwald M; Del Carpio J
    Can Respir J; 2022; 2022():9355606. PubMed ID: 36124286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study.
    Yang JM; Koh HY; Moon SY; Yoo IK; Ha EK; You S; Kim SY; Yon DK; Lee SW
    J Allergy Clin Immunol; 2020 Oct; 146(4):790-798. PubMed ID: 32810517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps.
    Assaf SM; Tarasevych SP; Diamant Z; Hanania NA
    Curr Opin Pulm Med; 2021 Jan; 27(1):45-53. PubMed ID: 33065601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.